Advertisement - Members don't see this ad
Has anyone been following this?
26yo dental student. etoh pancreatitis. On admission deteriorated and was admitted to ICU. Sounds like passed of complications of etoh withdrawal. I obviously only have limited details.
I know telehealth has a big variety of takes on how people feel about it. Me, I feel very nuanced. It's like a medication, you can't just give it to anyone. It's the right choice in some cases, not in others, the diagnosis or clinical picture is fluid and not static. I definitely feel like it's been used in inappropriate ways and is vulnerable to abuse/misuse. Not saying that is what happened here necessarily. Likely his clinical picture changed rapidly. But, this is one of the reasons I err on more in person than not. You just don't know what will come through your door, whether it's a new patient or established patient. Depression can evolve to actually be bipolar. Your high functioning executive on low dose prozac can have etoh withdrawal. If you happen to be on a screen...it's just a lot harder.
I mean, this is ICU which is a whole different beast. But...as some know from my other posts, I've ran into more risks in running the practice when providers tried to increase their telehealth and stay home and decrease in person days (in a non-judicious manner). This included decompensated eating disorders, missing complications of etoh use (e.g. evidences of liver disease like ascites or jaundice that affects prescribing decisions), tardive dyskinesia. I mean, the patient won't be aware of what to look out for, that's why we're the experts and we notice things when we see them. Like wow, they look really jaundiced. Oh, they are really thin...that's why they wanted to stay remote. Patient thought it was "just a tic" or quirk but it was TD.
Opinions aside, I think it's a great discussion the article brings.
26yo dental student. etoh pancreatitis. On admission deteriorated and was admitted to ICU. Sounds like passed of complications of etoh withdrawal. I obviously only have limited details.
I know telehealth has a big variety of takes on how people feel about it. Me, I feel very nuanced. It's like a medication, you can't just give it to anyone. It's the right choice in some cases, not in others, the diagnosis or clinical picture is fluid and not static. I definitely feel like it's been used in inappropriate ways and is vulnerable to abuse/misuse. Not saying that is what happened here necessarily. Likely his clinical picture changed rapidly. But, this is one of the reasons I err on more in person than not. You just don't know what will come through your door, whether it's a new patient or established patient. Depression can evolve to actually be bipolar. Your high functioning executive on low dose prozac can have etoh withdrawal. If you happen to be on a screen...it's just a lot harder.
I mean, this is ICU which is a whole different beast. But...as some know from my other posts, I've ran into more risks in running the practice when providers tried to increase their telehealth and stay home and decrease in person days (in a non-judicious manner). This included decompensated eating disorders, missing complications of etoh use (e.g. evidences of liver disease like ascites or jaundice that affects prescribing decisions), tardive dyskinesia. I mean, the patient won't be aware of what to look out for, that's why we're the experts and we notice things when we see them. Like wow, they look really jaundiced. Oh, they are really thin...that's why they wanted to stay remote. Patient thought it was "just a tic" or quirk but it was TD.
Opinions aside, I think it's a great discussion the article brings.